ClinicalTrials.Veeva

Menu

Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome

K

khalid abd aziz mohamed

Status and phase

Completed
Phase 3
Phase 2

Conditions

Infertility

Treatments

Drug: Calcium Dobesilate
Other: coasting

Study type

Interventional

Funder types

Other

Identifiers

NCT02290002
ahmed-khalid 8

Details and patient eligibility

About

The purpose of this study is to compare the effect of oral Calcium Dobesilate versus costing in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).

Full description

Two hundred and twenty women at risk of ovarian hyperstimulation syndrome during ICSI cycles will be randomly scheduled into two equal groups. In group A, (Calcium Dobesilate group), 1 cap / 8 hs Doxium ( 500mg) will be given at day of HCG injection and for 3 weeks ; while in group B (Coasting group), coasting (withholding gonadotrophins while maintaining pituitary suppression) follow up every day by measuring E2 for 3 days then either giving triggering or cycle cancellation is done

Enrollment

200 patients

Sex

Female

Ages

23 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infertile women undergoing intracytoplasmic sperm injection or polycystic ovarian syndrome (PCO) with one of the following:

    • Presence of more than 20 follicles by ultrasound
    • E2 more than 3000 pg/ml
    • Retrieval of more than 15 follicles

Exclusion criteria

  • None

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

group A
Active Comparator group
Description:
In group A, (Calcium Dobesilate group), 1 cap / 8 hs Calcium Dobesilate ( 500mg) will be given from at day of HCG injection and for 21 days.
Treatment:
Drug: Calcium Dobesilate
group B
Active Comparator group
Description:
In group B, coasting (withholding gonadotrophins while maintaining pituitary suppression) for 3 days then either giving triggering or cycle cancellation is done
Treatment:
Other: coasting

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems